Related Experiment Video

Updated: Dec 19, 2025

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.7K

Small Ones to Fight a Big Problem-Intervention of Cancer Metastasis by Small Molecules

Dennis Kobelt1,2, Mathias Dahlmann1,2, Malti Dumbani1

  • 1Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.

Cancers
|June 7, 2020
PubMed

Insights

Targeting cancer metastasis, the deadliest cancer trait, with novel small molecule therapies is crucial. Identifying high-risk patients and metastasis drivers enables personalized treatments to improve survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Metastasis is the primary cause of cancer mortality, significantly limiting treatment efficacy.
  • Developing targeted therapies to restrict solid tumor metastasis is a critical clinical need.
  • Identifying biomarkers for metastasis risk and drivers is essential for effective intervention.

Purpose of the Study:

  • To review the biological steps of the metastatic cascade.
  • To discuss therapeutic strategies targeting metastasis.
  • To explore the role of small molecules in cancer therapy.

Main Methods:

  • Literature review of the metastatic cascade.
  • Analysis of metastasis suppressors and drivers.
  • Discussion of small molecule-based therapeutic interventions.

Main Results:

  • Metastasis involves critical steps: cell dissemination, migration, and invasion.
  • Metastasis suppressors play a key role in controlling cancer spread.
  • Targeting key metastatic molecules offers potential for personalized therapy.

Conclusions:

  • Effective cancer therapy requires restricting metastasis, the leading cause of death.
  • Novel molecularly targeted small molecule therapies are needed to combat metastasis.
  • Personalized interventions based on metastasis biomarkers can improve patient survival.
Keywords:
cancer metastasisinhibitorsinterventionsmall moleculessolid cancer

More Related Videos

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.4K
Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

17.2K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K